GlassScriptPhysician profile
Nidal Ganim
NPI 1104244680
$4,789.56
in general payments reported to CMS, 2019-2025
26 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.66 · 2020: $134 · 2021: $140 · 2022: $326 · 2023: $1,686 · 2024: $1,195 · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,150.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,084.14 | 2020-2025 | Watchman Flx, Watchman Access System |
| Abbott Laboratories | $968.48 | 2021-2025 | Aveir, Cardiomems, Ensite Precision |
| Cvrx, INC. | $411.19 | 2022-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $410.31 | 2022-2025 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $361.19 | 2024-2025 | Assure Wcd |
| Heartflow, INC. | $204.74 | 2025 | |
| Novo Nordisk INC | $186.21 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Novartis Pharmaceuticals Corporation | $150.74 | 2023-2025 | |
| Pfizer INC. | $122.38 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $120.91 | 2021-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $110.08 | 2022-2025 | Verquvo |
| Canon Medical Systems USA, INC. | $98.86 | 2023 | Pet-Ct Scanner |
| Impulse Dynamics (USA) INC. | $93.53 | 2022-2023 | Optimizer |
| Biosense Webster, INC. | $75.31 | 2023-2024 | Nuvision Ice Catheter, Carto 3 |
| Amgen INC. | $73.51 | 2019-2023 | Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $61.76 | 2021-2022 | |
| Astellas Pharma US INC | $46.47 | 2019-2021 | |
| Cardiva Medical, INC. | $45.37 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Tactile Systems Technology INC | $40.31 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $27.06 | 2025 | Evkeeza |
| Itamar Medical INC | $19.64 | 2023 | Watchpatone |
| Inspire Medical Systems, INC. | $18.00 | 2024 | Inspire |
| Irhythm Technologies, INC. | $16.11 | 2023 | Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $15.65 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.21 | 2023 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $13.40 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidal Ganim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.